North India Statesman
[ad_1]
The owner of Tamil Nadu pharmaceutical company ‘Sreesan Pharma’ has been arrested. This is the same company that manufactured ‘Coldriff Cough Syrup’, in which adulteration was found and due to which children were dying in many states. The owner of this company, Ranganathan, has been arrested by Madhya Pradesh Police from Chennai. Many children had died after drinking this poisonous syrup and a reward of Rs 20,000 was also announced for his arrest.
What is Coldrif syrup?
Coldrif is a medicine given to children to treat cold and cough symptoms such as runny nose, sneezing, sore throat and watery eyes. Tests conducted by Tamil Nadu authorities found a sample of the syrup to contain “diethylene glycol”, a toxic and harmful substance, and it was declared adulterated. India’s top drug regulator has admitted serious flaws in drug manufacturing practices. In one of its advisories, it said that inspections of several factories found that companies were not checking the raw materials and active ingredients of each batch.
Preparations are underway to take action against the company after large-scale manipulation in the syrup was found. Making a serious revelation, Tamil Nadu DCD has taken strict action against the factory of Srisan Pharmaceutical Manufacturers. The department has immediately stopped production at the factory and started the process of canceling the manufacturing license.
Other syrup samples were taken.
The DCD also took samples of four other syrups and seized the stock present in the factory and stopped further distribution. Priority testing was done at the Government Drug Testing Laboratory in Chennai and a statewide alert was issued directing to stop distribution at wholesale and retail levels. Odisha and Puducherry were also informed through email.
Which samples were taken:
Respolite D (Batch- SR-30), Respolite GL (Batch- SR-45), Respolite ST (Batch- SR-22), Hepasandin (Batch- SR-46)
Samples for checking, regardless of holidays
They were sent to the Government Drug Testing Laboratory in Chennai, where testing was done on priority basis despite being on leave. Inspections conducted on October 2 revealed more irregularities and a statewide alert was issued thereafter. The distribution list was sent to all the drug inspectors. So that the stock can be seized at wholesale and retail level. Besides, orders were also issued to other states in this regard.
